Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9AV57
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.576 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 281 | 283 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.702 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.694 |
CLV_PCSK_FUR_1 | 202 | 206 | PF00082 | 0.572 |
CLV_PCSK_FUR_1 | 279 | 283 | PF00082 | 0.405 |
CLV_PCSK_FUR_1 | 39 | 43 | PF00082 | 0.703 |
CLV_PCSK_KEX2_1 | 204 | 206 | PF00082 | 0.498 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.261 |
CLV_PCSK_KEX2_1 | 228 | 230 | PF00082 | 0.425 |
CLV_PCSK_KEX2_1 | 264 | 266 | PF00082 | 0.470 |
CLV_PCSK_KEX2_1 | 281 | 283 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.702 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.632 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.693 |
CLV_PCSK_PC1ET2_1 | 204 | 206 | PF00082 | 0.498 |
CLV_PCSK_PC1ET2_1 | 228 | 230 | PF00082 | 0.428 |
CLV_PCSK_PC1ET2_1 | 264 | 266 | PF00082 | 0.470 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.705 |
CLV_PCSK_PC7_1 | 224 | 230 | PF00082 | 0.499 |
CLV_PCSK_PC7_1 | 4 | 10 | PF00082 | 0.686 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 159 | 163 | PF00082 | 0.573 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 205 | 209 | PF00082 | 0.343 |
DEG_APCC_DBOX_1 | 186 | 194 | PF00400 | 0.404 |
DOC_CYCLIN_RxL_1 | 224 | 238 | PF00134 | 0.677 |
DOC_MAPK_gen_1 | 228 | 234 | PF00069 | 0.685 |
DOC_MAPK_RevD_3 | 208 | 224 | PF00069 | 0.343 |
DOC_PP1_RVXF_1 | 202 | 209 | PF00149 | 0.298 |
DOC_USP7_UBL2_3 | 155 | 159 | PF12436 | 0.280 |
DOC_WW_Pin1_4 | 243 | 248 | PF00397 | 0.663 |
DOC_WW_Pin1_4 | 64 | 69 | PF00397 | 0.553 |
DOC_WW_Pin1_4 | 81 | 86 | PF00397 | 0.462 |
LIG_14-3-3_CanoR_1 | 121 | 129 | PF00244 | 0.397 |
LIG_14-3-3_CanoR_1 | 268 | 274 | PF00244 | 0.690 |
LIG_14-3-3_CanoR_1 | 9 | 17 | PF00244 | 0.506 |
LIG_BRCT_BRCA1_1 | 18 | 22 | PF00533 | 0.487 |
LIG_BRCT_BRCA1_1 | 74 | 78 | PF00533 | 0.540 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.388 |
LIG_FHA_2 | 122 | 128 | PF00498 | 0.386 |
LIG_FHA_2 | 132 | 138 | PF00498 | 0.405 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.462 |
LIG_FHA_2 | 270 | 276 | PF00498 | 0.630 |
LIG_LIR_Apic_2 | 76 | 82 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 212 | 222 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 241 | 249 | PF02991 | 0.758 |
LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.343 |
LIG_Pex14_1 | 214 | 218 | PF04695 | 0.343 |
LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.606 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.411 |
LIG_SUMO_SIM_par_1 | 67 | 72 | PF11976 | 0.412 |
MOD_CK1_1 | 72 | 78 | PF00069 | 0.763 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.775 |
MOD_CK2_1 | 121 | 127 | PF00069 | 0.567 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.462 |
MOD_CK2_1 | 251 | 257 | PF00069 | 0.744 |
MOD_CK2_1 | 269 | 275 | PF00069 | 0.459 |
MOD_CK2_1 | 74 | 80 | PF00069 | 0.758 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.605 |
MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.562 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.739 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.606 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.466 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.580 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.783 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.668 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.692 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.621 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.478 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.448 |
MOD_NEK2_1 | 269 | 274 | PF00069 | 0.591 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.624 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.765 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.561 |
MOD_PIKK_1 | 169 | 175 | PF00454 | 0.480 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.516 |
MOD_PKA_2 | 267 | 273 | PF00069 | 0.686 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.615 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.609 |
MOD_Plk_1 | 165 | 171 | PF00069 | 0.464 |
MOD_Plk_2-3 | 26 | 32 | PF00069 | 0.445 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.343 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.692 |
MOD_ProDKin_1 | 243 | 249 | PF00069 | 0.576 |
MOD_ProDKin_1 | 64 | 70 | PF00069 | 0.695 |
MOD_ProDKin_1 | 81 | 87 | PF00069 | 0.576 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.489 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.451 |
TRG_ER_diArg_1 | 132 | 135 | PF00400 | 0.492 |
TRG_ER_diArg_1 | 222 | 224 | PF00400 | 0.440 |
TRG_ER_diArg_1 | 7 | 9 | PF00400 | 0.612 |
TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 230 | 235 | PF00026 | 0.553 |
TRG_Pf-PMV_PEXEL_1 | 276 | 280 | PF00026 | 0.627 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIJ9 | Leptomonas seymouri | 60% | 100% |
A0A3S7WWJ0 | Leishmania donovani | 88% | 100% |
A4HBT5 | Leishmania braziliensis | 80% | 100% |
A4HZM4 | Leishmania infantum | 89% | 100% |
Q4QCC4 | Leishmania major | 89% | 100% |